Nanox is trying to turn Zebra Medical Vision’s scan-reading software into a hospital business, not just an AI demo. The company said it had accelerated work around Nanox.AI, added Cedars-Sinai as a clinical-trial partner for an aortic valve calcification tool and pushed U.S. deployment of Nanox.ARC systems, with Chief Executive Erez Meltzer calling the fourth quarter “strong momentum.”
The answer to the headline question “How many jobs have been lost to AI in 2023?” is not millions. Using Challenger, Gray & Christmas data, U.S. employers linked 4,247 announced job cuts to artificial intelligence in 2023, based on the firm’s January 2024 figure of 4,628 AI-linked cuts since May 2023, including 381 that January; Andrew Challenger said companies were “not outright blaming AI” for many layoff decisions.
Visa delivered more than just a headline beat this quarter, with spending, payment volume, cross-border volume, and processed transactions each rising by double digits.…
#2BUY
Hubbell
NYSE: HUBB92 / 100
Hubbell boosted its sales and profit outlook following strong double-digit organic growth. Although shares dipped 2.8% on Tuesday, the company’s operating performance is on…
#3BUY ON PULLBACK
Xylem
NYSE: XYL90 / 100
Xylem reported $3.1 billion in orders last quarter, providing clearer visibility than the modest 2% revenue growth indicates. Demand for water treatment is rising…
#4ACCUMULATE
Ford
NYSE: F86 / 100
Ford’s updated cash forecast stands out compared to its market capitalization. Strong truck pricing, product mix, and cost discipline supported this quarter. However, the…
#5TACTICAL BUY
SoFi
NASDAQ: SOFI82 / 100
SoFi boosted its revenue outlook following record growth in members, loan originations, and profit. Lending remains robust, but technology platform revenue dropped 23% year-over-year.…